"
A model System for Validation of PET Radiopharmaceuticals: Focusing on Tumor Microenvironment"
written by Xiao-Feng Li, Huijie Jiang, Yuanyuan Ma, Tao Huang, Xindao Yin, A. Cahid Civelek, Baozhong Shen,
published by
International Journal of Medical Physics, Clinical Engineering and Radiation Oncology,
Vol.2 No.1, 2013
has been cited by the following article(s):
[1]
|
Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination
PLOS ONE,
2018
DOI:10.1371/journal.pone.0206706
|
|
|
[2]
|
Abdomen and Thoracic Imaging
2014
DOI:10.1007/978-1-4614-8498-1_20
|
|
|
[3]
|
18F-Fluorodeoxyglucose Uptake and Tumor Hypoxia: Revisit 18F-Fluorodeoxyglucose in Oncology Application
Translational Oncology,
2014
DOI:10.1016/j.tranon.2014.02.010
|
|
|
[4]
|
Abdomen and Thoracic Imaging
2014
DOI:10.1007/978-1-4614-8498-1_20
|
|
|
[5]
|
The Usefulness of Combined Diagnostic CT and99mTc-Octreotide Somatostatin Receptor SPECT/CT Imaging on Pulmonary Nodule Characterization in Patients
Cancer Biotherapy & Radiopharmaceuticals,
2013
DOI:10.1089/cbr.2013.1482
|
|
|
[6]
|
Combined Injection of 18F-Fluorodeoxyglucose and 3′-Deoxy-3′-[18F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study
Translational Oncology,
2013
DOI:10.1593/tlo.13577
|
|
|